CRBP
Corbus Pharmaceuticals Holdings, Inc.NASDAQHealthcare$10.17+1.90%ClosedMarket Cap: $127.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.92
P/S
0.00
EV/EBITDA
0.00
DCF Value
$1.97
FCF Yield
-50.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-65.8%
ROA
-46.7%
ROIC
-57.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-22.0M | $-20.6M | $-1.25 | — |
| FY 2025 | $0.00 | -Infinity% | $-85.3M | $-78.5M | $-5.90 | — |
| Q3 2025 | $0.00 | NaN% | $-24.4M | $-23.3M | $-1.90 | — |
| Q2 2025 | $0.00 | -Infinity% | $-19.2M | $-17.7M | $-1.44 | — |
| Q1 2025 | $0.00 | -Infinity% | $-19.8M | $-17.0M | $-1.39 | — |
| Q4 2024 | $0.00 | -Infinity% | $-12.6M | $-9.5M | $-0.78 | — |
| FY 2024 | $0.00 | -Infinity% | $-48.7M | $-40.2M | $-3.68 | — |
| Q3 2024 | $0.00 | NaN% | $-15.5M | $-13.8M | $-1.15 | — |
| Q2 2024 | $0.00 | -Infinity% | $-11.0M | $-10.0M | $-3.55 | — |
| Q1 2024 | $0.00 | NaN% | $-9.6M | $-6.9M | $-2.45 | — |
| Q4 2023 | $0.00 | -Infinity% | $-10.1M | $-8.0M | $-1.81 | — |
| FY 2023 | $0.00 | NaN% | $-45.1M | $-44.6M | $-10.31 | — |